Zolistra 4mg inj

Price 3440 INR/ Thousand

Get a Price/Quote

Zolistra 4mg inj Specification

Origin of Medicine
Allopathic

Dosage Form
Injection

Salt Composition
Zoledronic Acid 4 mg

Indication
Treatment of hypercalcemia of malignancy, bone metastases, osteoporosis, Pagets disease

Pacakaging (Quantity Per Box)
Single Vial per Box

Drug Type
Prescription drug

Ingredients
Zoledronic Acid 4mg

Physical Form
Injection

Function
Antineoplastic and bone resorption inhibitor

Recommended For
Adults with bone metastases, osteoporosis, Pagets disease

Dosage
As directed by physician

Dosage Guidelines
Intravenous infusion only, to be diluted before use

Suitable For
Adults

Quantity
4 mg per vial

Storage Instructions
Store below 30C, protect from light

Contraindications
Known hypersensitivity to Palonosetron or similar agents

Marketing Authorization Holder
Zolon Healthcare Pvt. Ltd.

Shelf Life
2 years from manufacture date

Regulatory Approval
DCGI Approved

Brand Name
Zolistra

Route of Administration
Intravenous (IV)

Prescription Required
Yes

Therapeutic Class
Antiemetic

Molecular Formula
C19H24N2O

About Zolistra 4mg inj

Zolistra 4mg contains the active substance Zoledronic Acid. It belongs to the group of substances called bisphosphonates. It is used to reduce the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumor. Tumors can accelerate normal bone change in such a way that the release of calcium from bone is increased. This condition is known as tumor-induced hypercalcemia (TIH). It is also used to prevent bone complications in adult patients with multiple myeloma and bone metastases from solid tumors (spread of cancer from the primary site to the bone), in addition to standard cancer therapy.Zolistra 4mg is also indicated to prevent or treat osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause. It is also used to treat osteoporosis in men. It is used to treat Pagets disease of bone (a condition in which the bones are soft and weak and may be deformed, painful, or easily broken). Other uses include treating or preventing osteoporosis in men and women taking glucocorticoids (a corticosteroid medication that may cause osteoporosis).Do not take this injection if you are allergic to zoledronic acid, another bisphosphonate, or any other ingredients of this medicine and if you are pregnant or breastfeeding. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, pain, swelling, or jaw numbness. This medicine is not recommended for use in adolescents and children below the age of 18 years. Zolistra 4mg is not cancer chemotherapy and will not slow or stop the spread of cancer. However, it can be used to treat bone diseases in patients with cancer.

Comprehensive Bone Health Support

Zolistra 4mg Injection targets various bone conditions, including osteoporosis, bone metastases, Pagets disease, and malignancy-related hypercalcemia. As an allopathic prescription medicine, it offers substantial therapeutic benefits for adult patients needing effective bone resorption inhibition and antineoplastic support.

Safe and Regulated Administration

The injection is for intravenous use only and must be diluted before administration. It is prescribed and prepared by healthcare professionals to ensure patient safety. The medicine is provided in a single vial per box, ensuring accurate dosing and minimal waste.

Quality Assurance and Regulatory Compliance

Zolistra is manufactured and marketed in compliance with strict regulatory guidelines, including DCGI approval. It is produced under the supervision of Zolon Healthcare Pvt. Ltd., ensuring consistent quality and pharmaceutical standards for safe use and effective results.

FAQs of Zolistra 4mg inj:

Q: How should Zolistra 4mg Injection be administered?

A: Zolistra 4mg Injection must be given through intravenous infusion only and should be diluted prior to use. Administration should always be performed by a qualified healthcare provider following a physicians prescription and dosage guidelines.

Q: What conditions is Zolistra 4mg Injection recommended for?

A: Zolistra 4mg Injection is commonly used to treat adults with bone metastases, osteoporosis, Pagets disease, and hypercalcemia of malignancy, offering both antineoplastic and bone resorption inhibitory benefits.

Q: When should Zolistra 4mg Injection not be used?

A: This medication should not be used in individuals with known hypersensitivity to Zoledronic Acid or similar agents. Always inform your doctor about any allergic reactions to related medications before starting treatment.

Q: Where should Zolistra 4mg Injection be stored?

A: The injection should be stored below 30C and protected from light to preserve its potency. Always keep the medicine in its original packaging until it is ready for use by a healthcare professional.

Q: What is the shelf life of Zolistra 4mg Injection?

A: Zolistra 4mg Injection has a shelf life of 2 years from its manufacturing date, as long as it is stored according to the recommended conditions.

Q: What are the benefits of using Zolistra 4mg Injection?

A: The primary benefits include its ability to manage conditions related to excessive bone breakdown, such as in cancers with bone metastases or osteoporosis, helping to maintain bone strength and reduce complications of bone diseases.

Q: Why is a prescription required for Zolistra 4mg Injection?

A: Zolistra is a potent prescription medication with a specific mode of action and potential side effects. A doctors prescription ensures it is used appropriately, with professional monitoring for efficacy and safety.

Tell us about your requirement